is the glp 1 shortage over GLP-1 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Shortage = Over -

While weight loss may theoretically reduce mechanical stress on joints and muscles, there is no clinical evidence demonstrating that Ozempic provides benefit for fibromyalgia symptoms

He spoke at the Economic Club of D.C

Researchers continue to study the long-term effects of newer GLP-1 medications, including their impact on lean muscle mass

reported full-year worldwide revenue of about $65 billion in 2025, with Keytruda (pembrolizumab)/Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) sales amounting to roughly $31.7 billion and continuing to be the companys dominant growth engine, alongside contributions from pulmonary arterial hypertension (PAH) drug Winrevair (sotatercept-csrk), pneumonia vaccine Capvaxive (neumococcal 21-valent conjugate vaccine) and animal health products

One of healthcare's biggest tailwinds is the robust adoption of weight-loss drugs

LIV Body's brand-stated pricing ($179-$279/month depending on medication - confirm at checkout) is competitive but not necessarily the lowest in the category